| Anti-gitr antibodies and methods of use thereof |
2023-7-02 |
2023-9-01 |
|
| Antibodies and methods of use thereof |
2023-5-26 |
2023-7-28 |
|
| Anti-tim-3 antibodies and use methods thereof |
2023-4-19 |
2023-6-15 |
|
| Anti-CD137 antibodies and methods of use thereof |
2023-4-17 |
2023-5-11 |
|
| Anti-ctla-4 antibodies and methods of use thereof |
2023-3-21 |
2023-10-19 |
|
| Anti-ilt2 antibodies and uses thereof |
2023-3-07 |
2023-10-19 |
|
| Anti-pd-1 antibodies and methods of use thereof |
2023-2-09 |
2023-4-12 |
|
| T cell receptors that bind to ny-eso-1 and methods of use thereof |
2023-1-05 |
2023-3-03 |
|
| Anti-CD73 antibodies and methods of use thereof |
2022-10-27 |
2022-12-01 |
|
| Methods of administering anti-ox40 antibodies |
2022-9-08 |
2023-4-06 |
|
| Anti-TIGIT and anti-CD96 antibodies |
2022-8-10 |
2023-8-08 |
2023-8-08 |
| Antibodies and methods of use thereof |
2022-7-13 |
2022-9-26 |
|
| Identification of mhc class i phospho-peptide antigens from breast cancer … |
2022-7-08 |
2023-2-23 |
|
| Composition comprising at least two different complexes of a purified stress … |
2022-5-19 |
2022-7-01 |
|
| Anti-ox40 antibodies, anti-gitr antibodies, and methods of use thereof |
2022-5-09 |
2022-12-01 |
|
| Anti-tigit antibodies and methods of use thereof |
2022-5-04 |
2022-11-10 |
|
| Anti-tigit antibodies, anti-cd96 antibodies, and methods of use thereof |
2022-5-04 |
2023-10-26 |
|
| Anti-lag-3 antibodies and methods for use thereof |
2022-4-27 |
2022-7-14 |
|
| Anti-ctla-4 antibodies and methods of use thereof |
2022-3-27 |
2022-5-01 |
|
| Heterodimeric proteins |
2022-3-22 |
2022-5-01 |
|
| Anti-ilt4 antibodies and antigen-binding fragments |
2022-3-18 |
2022-6-07 |
|
| ANTI-CD96 ANTIBODIES AND THEIR METHODS OF USE |
2022-2-23 |
2023-2-28 |
|
| Antigenic polypeptides and methods of use thereof |
2022-1-24 |
2022-8-18 |
|
| Antigenic polypeptides and methods of use thereof |
2022-1-24 |
2022-9-01 |
|
| Class I MHC Phosphopeptides For Cancer Immunotherapy And Diagnosis |
2021-10-12 |
2021-11-04 |
|
| Heat Shock Protein-Binding Peptide Compositions And Methods Of Use Thereof |
2021-6-17 |
2022-1-13 |
|
| Anti-tigit antibodies and methods of use thereof |
2021-4-26 |
2022-3-24 |
|
| Anti-ox40 antibodies and methods of use thereof |
2021-3-04 |
2021-10-21 |
|
| T cell receptors that bind to mixed lineage leukemia (mll)-specific … |
2020-3-03 |
2020-10-01 |
|
| Systems and methods for token-based reimbursement and disbursement |
2019-4-29 |
2019-11-07 |
|
| Engineered host cells and methods of use thereof |
2018-12-14 |
2019-10-04 |
|
| Engineered Nucleases and Their Uses for Nucleic Acid Assembly |
2018-5-17 |
2019-4-18 |
|
| Methods for preparing and using multichaperone-antigen complexes |
2018-1-09 |
2018-12-27 |
|
| ANTIBODIES AND METHODS OF ITS USE |
2017-12-12 |
2019-3-20 |
|
| Anti-ctla-4 antibodies and methods of use thereof |
2017-12-07 |
2022-12-23 |
|
| Anti-lag-3 antibodies and methods of use thereof |
2017-10-11 |
2022-9-30 |
|
| Anti-lag-3 antibodies and methods of use thereof |
2017-10-11 |
2022-9-30 |
|
| ANTI-LAG-3 ANTIBODIES AND METHODS TO USE THEM |
2017-10-11 |
2019-2-06 |
|
| ANTI-TIM-3 ANTIBODIES AND METHODS TO USE THEM |
2017-5-26 |
2018-9-12 |
|
| Anti-tim-3 antibodies and methods of use thereof |
2017-5-26 |
2022-5-27 |
|
| Cell Surface Display, Screening and Production of Proteins of Interest |
2017-3-28 |
2017-9-14 |
|
| Protected derivatives of 2-amino-4-phosphobutanoic acid |
2017-3-21 |
2017-9-28 |
|
| Identification of antigen- or ligand-specific binding proteins |
2017-1-27 |
2019-12-10 |
2019-12-10 |
| High throughput screening for biomolecules |
2016-12-08 |
2017-9-15 |
|
| Anti-ox40 antibodies and methods of use thereof |
2016-12-02 |
2018-10-10 |
|
| Anti-GITR antibodies and methods of use thereof |
2016-12-02 |
2018-6-07 |
|
| Anti-gitr antibodies and methods of use thereof |
2016-12-02 |
2017-6-08 |
|
| Vaccine for treatment and prevention of herpes simplex virus infection |
2016-9-12 |
2017-8-03 |
|
| ANTI-PD-1 ANTIBODIES AND THEIR METHODS OF USE |
2016-9-01 |
2017-11-22 |
|
| Method of inducing a t-cell response to phosphopeptides using nucleic acids … |
2016-8-12 |
2017-2-23 |
|
| ANTI-CTLA-4 ANTIBODIES AND METHODS OF USE OF THE SAME |
2016-5-27 |
2017-8-16 |
|
| Anti-ctla-4 antibodies and methods of use thereof |
2016-5-27 |
2022-1-13 |
|
| ANTI-OX40 ANTIBODIES AND METHODS FOR USE |
2016-5-06 |
2017-8-09 |
|
| Methods for treating cancer |
2016-4-22 |
2018-11-08 |
|
| Methods and compositions for high throughput screening of biomolecules using … |
2016-3-10 |
2016-9-15 |
|
| Identification of antigen- or ligand-specific binding proteins |
2014-12-11 |
2015-1-22 |
|
| Methods and compositions for the treatment of glioblastomas |
2013-4-16 |
2013-10-24 |
|
| Binding members for human cytomegalovirus |
2012-6-22 |
2016-5-24 |
2016-5-24 |
| Retroviral vector particles and methods for their generation and use |
2010-11-22 |
2014-3-04 |
2014-3-04 |